advertisement

WGA Rescources

Sarkisian SR 10

Showing records 1 to 10 | Display all abstracts from Sarkisian SR

119146 Standalone interventional glaucoma: evolution from the combination-cataract paradigm
Micheletti JM; Micheletti JM
Journal of Cataract and Refractive Surgery 2024; 50: 1284-1290
124893 Long-Term Safety and Efficacy Evaluation of Travoprost Intracameral Implant Based on Pooled Analyses from Two Phase III Trials
Singh IP; Berdahl JP
Drugs 2024; 84: 1299-1311
119146 Standalone interventional glaucoma: evolution from the combination-cataract paradigm
Brink M
Journal of Cataract and Refractive Surgery 2024; 50: 1284-1290
124893 Long-Term Safety and Efficacy Evaluation of Travoprost Intracameral Implant Based on Pooled Analyses from Two Phase III Trials
Sarkisian SR
Drugs 2024; 84: 1299-1311
119146 Standalone interventional glaucoma: evolution from the combination-cataract paradigm
Brubaker JW
Journal of Cataract and Refractive Surgery 2024; 50: 1284-1290
124893 Long-Term Safety and Efficacy Evaluation of Travoprost Intracameral Implant Based on Pooled Analyses from Two Phase III Trials
Voskanyan LA
Drugs 2024; 84: 1299-1311
119146 Standalone interventional glaucoma: evolution from the combination-cataract paradigm
Ristvedt D
Journal of Cataract and Refractive Surgery 2024; 50: 1284-1290
124893 Long-Term Safety and Efficacy Evaluation of Travoprost Intracameral Implant Based on Pooled Analyses from Two Phase III Trials
Ang RE
Drugs 2024; 84: 1299-1311
119146 Standalone interventional glaucoma: evolution from the combination-cataract paradigm
Sarkisian SR
Journal of Cataract and Refractive Surgery 2024; 50: 1284-1290
124893 Long-Term Safety and Efficacy Evaluation of Travoprost Intracameral Implant Based on Pooled Analyses from Two Phase III Trials
Doan LV; Doan LV; Applegate D; Shen Y; Katz LJ; Kothe AC; Navratil T
Drugs 2024; 84: 1299-1311

Issue 25-1

Change Issue


advertisement

Topcon